Integration of palliative care in end-stage liver disease and liver transplantation

J Palliat Med. 2014 Nov;17(11):1271-7. doi: 10.1089/jpm.2013.0167.


Background: Patients with end-stage liver disease (ESLD) have a life-limiting illness that causes multiple distressing symptoms and negatively affects quality of life (QOL). This population traditionally has not had much attention within the palliative care community.

Discussion: This article provides an evidence-based review of palliative care issues that patients with ESLD and those awaiting liver transplant face, including approaches to prognosis, symptom management, advance care planning, and end-of-life care.

Conclusion: Tremendous opportunity exists to integrate palliative medicine into the care of these patients.

Publication types

  • Review

MeSH terms

  • Advance Directives
  • Delivery of Health Care, Integrated / methods*
  • End Stage Liver Disease / therapy*
  • Evidence-Based Medicine
  • Humans
  • Liver Transplantation*
  • Palliative Care*
  • Prognosis
  • Terminal Care*